Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral findings in children and adolescents with Prader-Willi syndrome.
Olczak-Kowalczyk D, Korporowicz E, Gozdowski D, Lecka-Ambroziak A, Szalecki M. Olczak-Kowalczyk D, et al. Among authors: szalecki m. Clin Oral Investig. 2019 Mar;23(3):1331-1339. doi: 10.1007/s00784-018-2559-y. Epub 2018 Jul 14. Clin Oral Investig. 2019. PMID: 30006686
ROHHAD in a 9-year-old boy — clinical case.
Kot K, Moszczyńska E, Lecka-Ambroziak A, Migdał M, Szalecki M. Kot K, et al. Among authors: szalecki m. Endokrynol Pol. 2016;67(2):226-31. doi: 10.5603/EP.a2016.0037. Endokrynol Pol. 2016. PMID: 26884306 Free article.
Detection of new potentially pathogenic mutations in two patients with primary pigmented nodular adrenocortical disease (PPNAD) - case reports with literature review.
Pasternak-Pietrzak K, Stratakis CA, Moszczyńska E, Lecka-Ambroziak A, Staniszewski M, Wątrobińska U, Lyssikatos C, Prokop-Piotrkowska M, Grajkowska W, Pronicki M, Szalecki M. Pasternak-Pietrzak K, et al. Among authors: szalecki m. Endokrynol Pol. 2018;69(6):675-681. doi: 10.5603/EP.a2018.0063. Epub 2018 Sep 27. Endokrynol Pol. 2018. PMID: 30259502 Free PMC article. Review.
Premature Adrenarche in Children with Prader-Willi Syndrome Treated with Recombinant Human Growth Hormone Seems to Not Influence the Course of Central Puberty and the Efficacy and Safety of the Therapy.
Lecka-Ambroziak A, Wysocka-Mincewicz M, Marszałek-Dziuba K, Rudzka-Kocjan A, Szalecki M. Lecka-Ambroziak A, et al. Among authors: szalecki m. Life (Basel). 2020 Oct 10;10(10):237. doi: 10.3390/life10100237. Life (Basel). 2020. PMID: 33050529 Free PMC article.
Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader-Willi Syndrome.
Lecka-Ambroziak A, Wysocka-Mincewicz M, Doleżal-Ołtarzewska K, Zygmunt-Górska A, Żak T, Noczyńska A, Birkholz-Walerzak D, Stawerska R, Hilczer M, Obara-Moszyńska M, Rabska-Pietrzak B, Gołębiowska E, Dudek A, Petriczko E, Szalecki M, On Behalf Of The Polish Coordination Group For rhGH Treatment. Lecka-Ambroziak A, et al. Among authors: szalecki m. Diagnostics (Basel). 2021 Apr 28;11(5):798. doi: 10.3390/diagnostics11050798. Diagnostics (Basel). 2021. PMID: 33925106 Free PMC article.
Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader-Willi Syndrome: A Polish Multicentre Study.
Lecka-Ambroziak A, Wysocka-Mincewicz M, Doleżal-Ołtarzewska K, Zygmunt-Górska A, Wędrychowicz A, Żak T, Noczyńska A, Birkholz-Walerzak D, Stawerska R, Hilczer M, Obara-Moszyńska M, Rabska-Pietrzak B, Gołębiowska E, Dudek A, Petriczko E, Szalecki M, On Behalf Of The Polish Coordination Group For rhGH Treatment. Lecka-Ambroziak A, et al. Among authors: szalecki m. J Clin Med. 2021 Jul 19;10(14):3176. doi: 10.3390/jcm10143176. J Clin Med. 2021. PMID: 34300343 Free PMC article.
129 results